Depo-Provera Linked to Increased HIV Risk in Africa

D

Medscape, January 09, 2015

The injectable contraceptive depot medroxyprogesterone (Depo-Provera or DMPA) is associated with elevated risk for HIV infection among women in low-income or middle-income countries of sub-Saharan Africa, according to a study.

The mechanism behind a link between DMPA and HIV infection is not known.

Read more here

By J Pope

Welcome to SASHA

SASHA is a current awareness service with news and views on various aspects of sexual health and sexuality, from a wide range of sources. These range from credible sources of sexual health and related information, to relevant opinion pieces in the media.

Categories